# Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

> **NCT06096077** · — · COMPLETED · sponsor: **Methodist Health System** · enrollment: 50 (actual)

## Conditions studied

- Angioedema

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06096077
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2023-08-23
- **Final completion:** 2023-08-23
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06096077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06096077, "Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06096077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*